Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Farde

Showing results (181-190 of 207) with videos related to

Pageof 21
Sort By:
Schizophrenia Bulletin|January 1, 1988
Workshop on schizophrenia, PET, and dopamine D2 receptors in the human neostriatumN C Andreasen, R Carson, M Diksic, et al.
Psychopharmacology|December 1, 1996
Autoradiographic localisation of D3-dopamine receptors in the human brain using the selective D3-dopamine receptor agonist (+)-[3H]PD 128907H Hall, C Halldin, D Dijkstra, et al.
Clinical Neuropharmacology|January 1, 1992
Ligand selection for PET studies of D1 dopamine receptors. Relationship between distribution of binding sites and mRNA for DAARPP32 in the human brainC G Sedvall, L Farde, H Hall, et al.
Nuclear Medicine and Biology|October 1, 1995
[O-methyl-11C]beta-CIT-FP, a potential radioligand for quantitation of the dopamine transporter: preparation, autoradiography, metabolite studies, and positron emission tomography examinationsC Lundkvist, C Halldin, C G Swahn, et al.
European Journal of Nuclear Medicine|February 1, 1994
Preparation of a potential positron emission tomographic radioligand for the dopamine transporterL Müller, C Halldin, C Foged, et al.
Acta Pharmaceutica Suecica|January 1, 1984
Preparation and preliminary positron emission tomography studies of 11C-Ro 15-1788, a selective benzodiazepine receptor antagonistE Ehrin, P Johnström, S Stone-Elander, et al.
European Journal of Nuclear Medicine|November 5, 1997
Bromine-76 and carbon-11 labelled NNC 13-8199, metabolically stable benzodiazepine receptor agonists as radioligands for positron emission tomographyC Foged, C Halldin, C Loc'h, et al.
The International Journal of Applied Radiation and Isotopes|April 1, 1985
Preparation of 11C-labelled Raclopride, a new potent dopamine receptor antagonist: preliminary PET studies of cerebral dopamine receptors in the monkeyE Ehrin, L Farde, T de Paulis, et al.
Brain Research|January 16, 1997
Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]way-100635H Hall, C Lundkvist, C Halldin, et al.
Nuclear Medicine and Biology|April 11, 2001
New halogenated [11C]WAY analogues, [11C]6FPWAY and [11C]6BPWAY--radiosynthesis and assessment as radioligands for the study of brain 5-HT1A receptors in living monkeyJ Sandell, C Halldin, V W Pike, et al.
Pageof 21

Showing results (181-190 of 207) with videos related to

Sort By:
Pageof 21
Schizophrenia Bulletin|January 1, 1988
Workshop on schizophrenia, PET, and dopamine D2 receptors in the human neostriatumN C Andreasen, R Carson, M Diksic, et al.
Psychopharmacology|December 1, 1996
Autoradiographic localisation of D3-dopamine receptors in the human brain using the selective D3-dopamine receptor agonist (+)-[3H]PD 128907H Hall, C Halldin, D Dijkstra, et al.
Clinical Neuropharmacology|January 1, 1992
Ligand selection for PET studies of D1 dopamine receptors. Relationship between distribution of binding sites and mRNA for DAARPP32 in the human brainC G Sedvall, L Farde, H Hall, et al.
Nuclear Medicine and Biology|October 1, 1995
[O-methyl-11C]beta-CIT-FP, a potential radioligand for quantitation of the dopamine transporter: preparation, autoradiography, metabolite studies, and positron emission tomography examinationsC Lundkvist, C Halldin, C G Swahn, et al.
European Journal of Nuclear Medicine|February 1, 1994
Preparation of a potential positron emission tomographic radioligand for the dopamine transporterL Müller, C Halldin, C Foged, et al.
Acta Pharmaceutica Suecica|January 1, 1984
Preparation and preliminary positron emission tomography studies of 11C-Ro 15-1788, a selective benzodiazepine receptor antagonistE Ehrin, P Johnström, S Stone-Elander, et al.
European Journal of Nuclear Medicine|November 5, 1997
Bromine-76 and carbon-11 labelled NNC 13-8199, metabolically stable benzodiazepine receptor agonists as radioligands for positron emission tomographyC Foged, C Halldin, C Loc'h, et al.
The International Journal of Applied Radiation and Isotopes|April 1, 1985
Preparation of 11C-labelled Raclopride, a new potent dopamine receptor antagonist: preliminary PET studies of cerebral dopamine receptors in the monkeyE Ehrin, L Farde, T de Paulis, et al.
Brain Research|January 16, 1997
Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]way-100635H Hall, C Lundkvist, C Halldin, et al.
Nuclear Medicine and Biology|April 11, 2001
New halogenated [11C]WAY analogues, [11C]6FPWAY and [11C]6BPWAY--radiosynthesis and assessment as radioligands for the study of brain 5-HT1A receptors in living monkeyJ Sandell, C Halldin, V W Pike, et al.
Pageof 21